Combining artificial intelligence assisted image segmentation and ultrasound based radiomics for the prediction of carotid plaque stability

PURPOSE: Utilizing artificial intelligence (AI) technology for the segmentation of plaques on ultrasound images to evaluate the stability of carotid artery plaques and analyze its diagnostic accuracy in differentiating vulnerable plaques from stable ones. METHODS: A retrospective study was conducted on 202 patients with ischemic stroke, who were divided into vulnerable plaque group (85 cases) and stable plaque group (117 cases) based on the results of carotid color Doppler ultrasound examination. From the vulnerable plaque group, 63 cases were randomly selected as the modeling group and 22 cases as the validation group; similarly, from the stable plaque group, 87 cases were randomly selected as the modeling group and 30 cases as the validation group. Based on the ultrasound images of the modeling group, plaques were segmented using artificial intelligence technology, and 1414 radiomics features were extracted. These features were then subjected to dimensionality reduction and feature selection using the least absolute shrinkage and selection operator (LASSO) method. Subsequently, a Support Vector Machine (SVM) model was constructed and validated using the selected features. The sensitivity, specificity, and Area Under the Curve (AUC) of the model were evaluated through the analysis of the receiver operating characteristic (ROC) curve. RESULTS: A total of 43 radiomics feature parameters were selected by the LASSO method. The training group for the SVM model had an AUC of 89.42% (95% CI: 80.74-98.10%), sensitivity of 79.84%, and specificity of 93.10%, while the validation group had an AUC of 82.73% (95% CI: 71.64-93.81%), sensitivity of 81.82%, and specificity of 80.00%. CONCLUSION: The use of artificial intelligence technology for the segmentation of plaques in ultrasound images, coupled with the analysis of radiomics models, can efficiently distinguish the stability of carotid artery plaques, providing a diagnostic basis for the clinical prediction of ischemic stroke. CLINICAL TRIAL NUMBER: Not applicable.